Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Pfizer lifts 2026 guidance as cancer, migraine sales offset Covid slide

Pfizer raised its 2026 financial guidance as strong growth in its oncology and migraine businesses helped it weather sharp sales drops in its Covid products. The company reported third-quarter sales and ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 3 November →